[Research progress on poor response, resistance mechanisms, and influencing factors of immunotherapy for hepatocellular carcinoma]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHuang M +5 more
europepmc +1 more source
[<i>Shengmai San</i> improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoLiang Z +6 more
europepmc +1 more source
[Oral mucosal administration]. [PDF]
Hua Xi Kou Qiang Yi Xue Za ZhiLiu T, Liu J, Zhao H.
europepmc +1 more source
[Interpretation of 2024 United Kingdom National Osteoporosis Guideline Group (NOGG) Clinical Guidelines: Prevention and Treatment of Osteoporosis]. [PDF]
Zhongguo Xiu Fu Chong Jian Wai Ke Za ZhiGao J, Wang B, Wang W, Ma J.
europepmc +1 more source
[Advances in ribosome biogenesis and targeted therapies for diffuse large B-cell lymphomas]. [PDF]
Zhonghua Xue Ye Xue Za ZhiYue MX, Zhao WL, Wang L.
europepmc +1 more source
[Clinical analysis of nusinersen for spinal muscular atrophy types 2 and 3 in children]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiDuan HL +6 more
europepmc +1 more source
[Mechanism and clinical progress of JAK inhibitors in hemophagocytic lymphohistiocytosis]. [PDF]
Zhonghua Xue Ye Xue Za ZhiWang MX +4 more
europepmc +1 more source